- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about BNTX
Recent news which mentions BNTX
Repeat COVID-19 Infection Increases Risk Of Acute Outcomes, Long COVID Symptoms, Study Shows
November 11, 2022
From Benzinga
Europe Approves Sanofi, GSK's Beta Variant Adapted COVID Shot As Booster
November 10, 2022
From Benzinga
WHO says 90% decline in COVID deaths since Feb. is ’cause for optimism,’ while urging vigilance against new variants
November 10, 2022
From MarketWatch
This COVID-19 Vaccine Stock Has More to Offer
November 10, 2022
From Motley Fool
2 Top Healthcare Stocks to Buy Right Now
November 10, 2022
From Motley Fool
Is It Time To Pay Attention To This Acellular Biologic Pioneer That Says Its Clinical Trials Are Cheaper And Easier?
November 10, 2022
From Benzinga
Return To Office: Pfizer To Enforce 2-3 Days In Office Starting January
November 09, 2022
From Benzinga
Novavax stock rallies, even as company offers a dimmer sales forecast for vaccines
November 08, 2022
From MarketWatch
The 7 Best Pharma Stocks to Buy Now
November 08, 2022
From InvestorPlace
From Motley Fool
All eyes on China as Apple and Foxconn outline zero-COVID issues. Meanwhile, cases are rising again in the U.S.
November 07, 2022
From MarketWatch
From Benzinga
BioNTech Posts About 50% Drop In Q3 Sales and Profits Amid Falling Demand For COVID-19 Shots
November 07, 2022
Tickers
BNTX
From Benzinga
Here’s how much China stocks still could rally from zero-COVID, say Goldman Sachs strategists
November 07, 2022
From MarketWatch
Did Vaccine Stocks Just Get Their Last Boost?
November 04, 2022
From Motley Fool
BioNTech's COVID-19 Vaccine Becomes First Foreign Shot To Be Available In Chinese Market
November 04, 2022
From Benzinga
Pfizer-BioNTech bivalent booster shows higher immune response, but new COVID cases climb back above 40,000 a day
November 04, 2022
From MarketWatch
Pfizer/BioNTech Updated Omicron Adapted COVID-19 Vaccine Shows 4-Fold Higher Neutralizing Activity
November 04, 2022
From Benzinga
From Benzinga
From MarketWatch
Why Inovio Pharmaceuticals Stock Zoomed Nearly 6% Higher Today
October 28, 2022
From Motley Fool
From Benzinga
Is BioNTech a Good Long-Term Buy?
October 27, 2022
From Motley Fool
From Motley Fool
Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday
October 24, 2022
From Benzinga
Moderna, Amazon, Tesla, And Other Big Gainers From Friday
October 24, 2022
From Benzinga
Why Novavax Stock Rose 12.57% on Friday
October 21, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.